CCOC(=O)CCC(C(=O)OCC)n1nc2ccc(Nc3c(C)[n+]([O-])c4cc(Cl)ccc4[n+]3[O-])cc2n1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?